König O, Bockmühl U, Haake K
Klinik für Audiologie und Phoniatrie der Charité--Universitätsmedizin Berlin, Campus Benjamin Franklin.
HNO. 2006 Feb;54(2):93-8. doi: 10.1007/s00106-005-1281-7.
Endoscopic laser resection is one treatment modality for early glottic carcinoma. Benefits are the preservation of laryngeal structure without tracheotomy, the short duration of treatment, low traumatisation and good functional results.
From 1989 to 1999, 143 patients with an isolated and previously untreated glottic squamous cell carcinoma were treated by CO2 endoscopic laser resection. The tumors were classified as carcinoma in situ (Tis) in seven cases, T1 tumor (T1N0M0) in 91 patients and T2 tumor (T2N0M0) in 45 cases. Median follow-up was 5 years.
For the group of Tis and T1 carcinomas, 86 of 98 patients were free of recurrences. The 12 recurrences (12.2%) were treated by repeated laser surgery and laryngectomy (four patients). None of these patients died of tumor related causes. For patients with T2 carcinomas, the overall recurrence rate was 28.9% (13 patients). In six patients, a total laryngectomy had to be performed and one patient died because of tumor recurrence. The relapse free survival estimate using the Kaplan-Meier method was 87% for Tis and T1 carcinomas and 70% for T2 carcinomas. The overall laryngeal preservation rate was 95% for Tis and T1 carcinomas and 85% for T2 tumors. All recurrences occurred within 4 years of primary surgery.
The results suggest that the oncological outcome after endoscopic laser surgery is comparable to conventional open partial resections.
内镜激光切除术是早期声门癌的一种治疗方式。其优点包括保留喉部结构无需气管切开、治疗时间短、创伤小以及功能效果良好。
1989年至1999年,143例孤立的、未经治疗的声门鳞状细胞癌患者接受了二氧化碳内镜激光切除术。肿瘤分类为原位癌(Tis)7例,T1期肿瘤(T1N0M0)91例,T2期肿瘤(T2N0M0)45例。中位随访时间为5年。
对于Tis和T1期癌组,98例患者中有86例无复发。12例复发患者(12.2%)接受了再次激光手术和喉切除术(4例患者)。这些患者均未死于肿瘤相关原因。对于T2期癌患者,总体复发率为28.9%(13例患者)。6例患者不得不进行全喉切除术,1例患者因肿瘤复发死亡。采用Kaplan-Meier法估计的无复发生存率,Tis和T1期癌为87%,T2期癌为70%。Tis和T1期癌的总体喉保留率为95%,T2期肿瘤为85%。所有复发均发生在初次手术后4年内。
结果表明内镜激光手术后的肿瘤学结果与传统开放性部分切除术相当。